November 20, 2024 NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board
October 21, 2024 NUCLIDIUM Announces First Patient Imaged in Phase 1 Study Evaluating 61Cu-based Radiotracer in Patients with PSMA-positive Prostate Cancer NUCLIDIUM Announces First Patient Imaged in Phase 1 Study Evaluating 61Cu-based Radiotracer in Patients with PSMA-positive Prostate Cancer
Tags Events / March 21, 2023 NUCLIDIUM at BioEquity & Swiss Biotech Days Our CEO Leila Jaafar will present the company and our unique copper-based approach at the upcoming conferences. Meet us there!